Profile
Mr. Doug Meislahn is a Commercialization Analyst at Cleveland Clinic Innovations.
He joined the firm in April 2007.
He is a registered patent agent whose primary role at CCI is to serve as the initial point of contact for researchers and physicians who are considering the commercial prospects of their inventions.
In this role, he advises inventors on their options, tracks incoming disclosures, and assembles background information for case managers.
Mr. Meislahn has previously worked for five years as a Patent Examiner by United States Patent & Trademark Office from September 1998 to August 2004.
Prior to joining CCI, Mr. Meislahn received his MBA from Carnegie Mellon University's Tepper School of Business in 2006.
He has received B.S in Physics from Davidson College in 1998.
Former positions of Doug Meislahn
| Companies | Position | End |
|---|---|---|
US Patent & Trademark Office
 US Patent & Trademark Office General GovernmentGovernment US Patent & Trademark Office provides patent and trade marks services. It advises the president of the United States, the secretary of commerce, and U.S. government agencies on intellectual property (IP) policy, protection, and enforcement; and promotes IP protection. The company is headquartered in Alexandria, VA. | Corporate Officer/Principal | 2004-07-31 |
Training of Doug Meislahn
| Carnegie Mellon University | Masters Business Admin |
| Davidson College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
US Patent & Trademark Office
US Patent & Trademark Office General GovernmentGovernment US Patent & Trademark Office provides patent and trade marks services. It advises the president of the United States, the secretary of commerce, and U.S. government agencies on intellectual property (IP) policy, protection, and enforcement; and promotes IP protection. The company is headquartered in Alexandria, VA. | Government |
- Stock Market
- Insiders
- Doug Meislahn
